Dow Extends Losses In Mixed Stock Market; Biogen Soars 50% After FDA Nod - Investor's Business Daily
- Dow Extends Losses In Mixed Stock Market; Biogen Soars 50% After FDA Nod Investor's Business Daily
- Dow falls more than 100 points to start the week, S&P 500 struggles to reach new high CNBC
- Nasdaq rises on Biogen boost, S&P, Dow little changed Fox Business
- Why General Motors Stock Continues to be a Wall Street Favorite Barron's
- How major US stock indexes fared Monday Kansas City Star
- View Full Coverage on Google News
from Top stories - Google News
Dow Extends Losses In Mixed Stock Market; Biogen Soars 50% After FDA Nod - Investor's Business Daily
![Dow Extends Losses In Mixed Stock Market; Biogen Soars 50% After FDA Nod - Investor's Business Daily]()
Reviewed by Moltivie
on
June 08, 2021
Rating:
No comments: